Downstaging of T or N Predicts Long-Term Survival After Preoperative Chemotherapy and Radical Resection for Esophageal Carcinoma

Annals of Thoracic Surgery

Volumn 82, Issue 2, 2006, Pages 480-485

  Korst, Robert J ^a,b   Kansler, Amanda L ^a   Port, Jeffrey L ^a   Lee, Paul C ^a   Kerem, Yaniv ^a   Altorki, Nasser K ^a  

^a Division of Plastic Surgery   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOZAR; CARBOPLATIN; CELECOXIB; CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 33746049823     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.03.072     Document Type: Article

References (17)

1. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
2. Naunheim K.S., Petrosku P.J., Roy T.S., et al. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg 59 (1995) 1085-1091
3. Adelstein D.J., Rice T.W., Becker M., et al. Use of concurrent chemotherapy, accelerated fractional radiation, and surgery for patients with esophageal carcinoma. Cancer 80 (1997) 1011-1020
4. Poplin E., Fleming T., Leichman L., et al. Combined therapies for squamous cell carcinoma of the esophagus, a Southwest Oncology Group study (SWOG 8037). J Clin Oncol 5 (1987) 622-628
5. Rohatgi P., Swisher S.G., Correa A.M., et al. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104 (2005) 2365-2372
6. Kelson D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 (1998) 1979-1984
7. Ancona E., Ruol A., Santi S., et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma. Cancer 91 (2001) 2165-2174
8. Darton S.J., Archer V.R., Stocken D.D., Mulholland P.J., Casson A.G., and Ferry D.R. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus. pathologic complete response induced by chemotherapy leads to long-term survival. J Clin Oncol 21 (2003) 4009-4015
9. Keresztes R.S., Port J.L., Pasmantier M.W., Korst R.J., and Altorki N.K. Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin. results of a phase II trial. J Thorac Cardiovasc Surg 126 (2003) 1603-1608
10. Altorki N.K. En-bloc esophagectomy-the three-field dissection. Surg Clin North Am 85 (2005) 611-619
11. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer. a randomized controlled trial. Lancet 359 (2002) 1727-1733
12. Zuccaro Jr. G., Rice T.W., Goldblum J., et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 94 (1999) 906-912
13. Swisher S.G., Maish M., Erasmus J.J., et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78 (2004) 1152-1160
14. Rohatgi P., Swisher S.G., Correa A.M., et al. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104 (2005) 1349-1355
15. Mehta R.S., Bornstein R., Yu I.R., et al. Breast cancer survival and in vitro tumor response in the extreme drug resistance assay. Breast Cancer Res Treat 66 (2001) 225-237
16. Ozawa S., Imai Y., Suwa T., and Kitajima M. What's new in imaging? New magnetic resonance imaging of esophageal cancer using an endoluminal surface coil and antibody-coated magnetite particles. Recent Results Cancer Res 155 (2000) 73-87
17. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499